tiprankstipranks
PharmaNutra SpA (IT:PHN)
:PHN
Italy Market

PharmaNutra SpA (PHN) Technical Analysis

Compare
7 Followers

Summary of all the Indicators

Overall Consensus
Buy
15Bullish
2Neutral
5Bearish
Technical Analysis Consensus
Sell
3Bullish
2Neutral
5Bearish
Moving Average Consensus
Strong Buy
12Bullish
0Neutral
0Bearish
PharmaNutra SpA’s (PHN) Moving Averages Convergence Divergence (MACD) indicator is 0.36, suggesting PharmaNutra SpA is a Sell.
PharmaNutra SpA’s (PHN) 20-Day exponential moving average is 52.53, while PharmaNutra SpA’s (PHN) share price is €54.3, making it a Buy.
PharmaNutra SpA’s (PHN) 50-Day exponential moving average is 52.82, while PharmaNutra SpA’s (PHN) share price is €54.3, making it a Buy.

PharmaNutra SpA (PHN) Pivot Points

Feb 21, 2025, 03:59 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
53.07
53.43
53.87
54.23
54.67
55.03
55.47
Fibonacci
53.43
53.74
53.93
54.23
54.54
54.73
55.03
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

PharmaNutra SpA (PHN) Moving Averages

Feb 21, 2025, 03:59 PM
Period
Simple
Exponential
MA5
53.76Buy
53.84Buy
MA10
52.46Buy
53.03Buy
MA20
51.91Buy
52.53Buy
MA50
52.77Buy
52.82Buy
MA100
54.20Buy
53.26Buy
MA200
52.13Buy
52.76Buy
PharmaNutra SpA’s (PHN) 10-Day exponential moving average is 53.03, while PharmaNutra SpA’s (PHN) share price is €54.3, making it a Buy.
PharmaNutra SpA’s (PHN) 100-Day exponential moving average is 53.26, while PharmaNutra SpA’s (PHN) share price is €54.3, making it a Buy.
PharmaNutra SpA’s (PHN) stock price is €54.3 and PharmaNutra SpA’s (PHN) 50-day simple moving average is 52.77, creating a Buy signal.
PharmaNutra SpA’s (PHN) stock price is €54.3 and PharmaNutra SpA’s (PHN) 100-day simple moving average is 54.20, creating a Buy signal.
PharmaNutra SpA’s (PHN) stock price is €54.3 and PharmaNutra SpA’s (PHN) 200-day simple moving average is 52.13, creating a Buy signal.

PharmaNutra SpA (PHN) Technical Indicators

Feb 21, 2025, 03:59 PM
Name
Value
Implied Action
RSI (14)
66.81
Neutral
STOCH (9,6)
89.48
Sell
STOCHRSI (14)
90.42
Sell
MACD (12,26)
0.36
Sell
ADX (14)
19.97
Buy
Williams %R
-5.56
Sell
CCI (14)
219.56
Sell
ATR (14)
1.15
-
Ultimate Oscillator
63.66
Neutral
ROC
8.25
Buy
PharmaNutra SpA’s (PHN) Relative Strength Index (RSI) is 66.81, creating a Neutral signal.
PharmaNutra SpA’s (PHN) Trend Strength Indicator (ADX) is 19.97, creating a Buy signal.
PharmaNutra SpA’s (PHN) Commodity Channel Index (CCI) is 219.56, creating a Sell signal.
PharmaNutra SpA’s (PHN) Price Rate of Change (ROC) is 8.25, creating a Buy signal.

FAQ

Is PHN a Buy, Hold, or Sell?
Based on PHN’s technical indicators, PHN is a Buy.
    What is PHN’s RSI (14)?
    PHN’s RSI (14) is 66.81, which suggests PHN is a Neutral.
      What is PHN’s MACD?
      PHN’s MACD is 0.36, which suggests PHN is a Sell.
        What is PHN’s 5-day moving average?
        PHN’s 5-day moving average is 53.76, which suggests PHN is a Buy.
          What is PHN’s 20-day moving average?
          PHN 20-day moving average is 51.91, which suggests PHN is a Buy.
            What is PHN’s 50-day moving average?
            PHN’s 50-day moving average is 52.77, which suggests PHN is a Buy.
              What is PHN’s 200-day moving average?
              PHN’s 200-day moving average is 52.13, which suggests PHN is a Buy.
                What is PHN’s Williams % R (14)?
                PHN’s Williams % R (14) is -5.56, which suggests PHN is a Sell.
                  What is PHN’s CCI (14)?
                  PHN’s CCI (14) is 219.56, which suggests PHN is a Sell.
                    What is the share price of PharmaNutra SpA?
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis